The Locus-to-Gene (L2G) pipeline of Open Targets Genetics consortium finds USP24 as a prioritised gene for GWAS variants associated with LDL-C (L2G score: 0.7), estimated glomerular filtration rate (L2G score: ~0.6), various CVD (L2G score: ~0.8), metabolic disorders (L2G score: ~0.01) and various cancers (L2G score: ~0.06) [40]. This evidence concerns the gene USP24 and cancer.